查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1826814

2025年神经诊断全球市场报告

Neurodiagnostics Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，神经诊断市场规模强劲成长，从2024年的91.7亿美元增加至2025年的97.9亿美元，复合年增长率为6.8%。预测期内的成长可归因于神经系统疾病盛行率的上升、先进影像技术的普及、老年人口的增长、早期疾病诊断意识的增强、医疗基础设施的扩展以及神经科学研发投入的增加。

预计未来几年神经诊断市场将强劲成长，到2029年将达到126.8亿美元，复合年增长率为6.7%。预测期内的成长归因于对非侵入性诊断技术的需求不断增长、神经系统疾病盛行率不断上升、政府对医疗基础设施的投资不断增加、提高认知度和早期发现的努力，以及个人化医疗方法的扩展。预测期内的主要趋势包括可携式脑电图设备的发展、人工智慧的整合以提高诊断准确性、用于脑成像的核磁共振成像技术的改进、用于持续监测的可穿戴设备的采用、神经遗传学检测的进步以及实时数据分析在个性化治疗方案中的应用。

神经诊断学是一个专注于诊断和监测神经系统疾病（包括大脑、脊髓和周边神经）的医学领域。它利用先进的技术和测试来评估神经功能、检测异常，并诊断癫痫、中风、多发性硬化症、神经病变和其他神经系统疾病。

神经诊断工具的主要类型包括诊断影像解决方案和体外诊断。诊断和影像解决方案包括旨在透过各种成像技术和诊断工具检测健康状况的医疗技术和服务。该领域的关键技术包括神经影像学、电脑断层扫描 (CT)、磁振造影(MRI)、核子医学影像 (PET、SPECT)、近红外线光谱 (NIRS)、脑电图 (EEG)、脑磁图 (MEG)、基于体素的形态测量 (VBM) 和神经资讯学。这些诊断工具对于治疗癫痫、阿兹海默症、帕金森氏症、中风、关节健康问题等至关重要，并广泛应用于医院、诊所、诊断实验室、影像中心和其他医疗机构。

2025 年春季美国突然提高关税以及由此引发的贸易摩擦对医疗保健产业产生了重大影响，尤其是基本医疗设备、诊断设备和药品的供应。医院和医疗机构正努力应对进口手术器械、诊断影像系统以及注射器和导管等消耗品成本的上涨，其中许多产品的国内替代品有限。由于这些不断上涨的成本给医疗保健预算带来压力，一些医疗机构正在推迟设备升级或将增加的费用转嫁给患者。此外，原材料和零件的关税扰乱了关键药品和医疗设备的生产，导致供应链延迟。作为应对措施，该行业正在采用多样化的筹资策略，尽可能扩大本地生产，并寻求关键医疗产品的关税豁免。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供神经诊断市场统计数据，包括全球市场规模、区域份额、神经诊断市场份额的竞争对手、详细的神经诊断市场细分、市场趋势和商业机会，以及在神经诊断行业取得成功所需的数据。本研究报告对神经诊断行业的现状和未来趋势进行了详细分析，为您提供所需的全面观点。

未来五年6.7%的成长预测比我们先前的预测略有下降，下降了0.1%。这一下降主要源自于美国与其他国家之间关税的影响。征收关税可能会扰乱美国的神经系统治疗，因为这会增加来自瑞典和美国的定量脑电图 (EEG) 耳机和诱发电位测试设备的成本，从而可能危及癫痫症的诊断，并增加神经生理学实验室的费用。由于互惠关税以及日益加剧的贸易紧张局势和限制对全球经济和贸易的负面影响，其影响也将更加广泛。

神经系统疾病盛行率的不断上升预计将推动神经诊断市场的扩张。影响大脑、脊髓和神经的神经病变会导致各种认知、运动和感觉障碍。这些疾病的增加主要是由于人口老化、环境影响、生活方式改变、遗传和诊断技术的改进等因素。神经诊断对于准确识别、评估和监测这些疾病至关重要，有助于准确诊断、明智的治疗选择和有效管理神经系统问题。例如，2023 年 4 月，美国国家医学图书馆报告称，670 万美国人患有阿兹海默症，预计到 2060 年将增加到 1,380 万。神经系统疾病盛行率的不断上升正在推动神经诊断市场向前发展。

神经诊断市场的公司正专注于技术创新，包括先进的软体演算法，以提高诊断准确性并改善患者预后。这些先进的演算法利用人工智慧 (AI) 和机器学习技术来处理和分析数据，从而支援更明智的决策和诊断。例如，2023 年 10 月，美国医疗设备製造商 Ceribell Inc. 推出了其 ClarityPro AI 演算法，这代表了脑电病 (ESE) 诊断领域的重大进步。这款先进的软体与 Ceribell 脑电图系统集成，利用机器学习分析脑电图波形，并对疑似癫痫发作发出即时警报。 ClarityPro 是第一个获得 FDA 批准用于独立诊断的急性医疗设备，可持续监测大脑活动并提供可操作的见解，帮助临床医生做出更快、更明智的治疗决策。

2022年7月，专注于医疗保健领域的法国投资公司ArchiMed SAS以11亿美元收购了Natus Medical Incorporated。此次收购充分利用了Natus Medical在开髮用于筛检、诊断和治疗神经系统疾病的医疗设备的专业知识，巩固了ArchiMed在神经诊断领域的地位。

神经诊断市场包括提供脑电图 (EEG)、正子断层扫描 (PET)、脑脊髓液 (CSF) 分析和睡眠呼吸中止症诊断等服务的营业单位所获得的收益。市场价值还包括服务供应商销售的或包含在其服务产品中的相关产品的价值。神经诊断市场包括经颅磁刺激 (TMS) 设备、脑磁图 (MEG) 系统、睡眠多项生理检查(PSG) 设备和生物感测器的销售。该市场的价值是“出厂价”，即商品製造商或生产商向其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接向最终客户销售的商品价值。该市场中的商品价值还包括商品製造商销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球神经学诊断：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球神经诊断市场：增长率分析
  • 全球神经诊断市场表现：规模与成长，2019-2024
  • 全球神经诊断市场预测：规模与成长，2024-2029 年，2034 年
  • 全球神经诊断：总目标市场（TAM）

第六章 市场细分

  • 全球神经诊断市场类型、绩效及预测（2019-2024、2024-2029、2034）
  • 诊断和影像解决方案
  • 体外诊断
  • 全球神经诊断市场（按技术、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 神经影像技术
  • 电脑断层扫描（CT）
  • 磁振造影（MRI）
  • 核子医学扫描术诊断（PET、SPECT）
  • 近红外光光谱成像（NIRS）
  • 脑电图（EEG）
  • 脑磁图（MEG）
  • 基于体素的形态测量（VBM）
  • 神经资讯学
  • 全球神经诊断市场：依疾病状况、表现及预测，2019-2024 年、2024-2029 年、2034 年
  • 癫痫
  • 阿兹海默症
  • 帕金森氏症
  • 中风
  • 关节健康
  • 其他条件
  • 全球神经诊断市场最终用途、绩效及预测（2019-2024、2024-2029、2034）
  • 医院和诊所
  • 诊断实验室
  • 影像中心
  • 其他最终用途
  • 全球神经诊断市场：依诊断及影像解决方案细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • MRI（磁振造影）系统
  • CT（电脑断层扫描）扫描仪
  • EEG（脑电图）系统
  • EMG（肌电图）系统
  • MEG（脑磁图）系统
  • PET（正子断层扫描）扫描仪
  • SPECT（单光子发射电脑断层扫描）扫描仪
  • 功能性磁振造影（fMRI）系统
  • 颅内压监测仪
  • 全球神经诊断市场：体外诊断细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 血液诊断
  • 脑脊髓液（CSF）分析
  • 基因检测和生物标记
  • 神经化学诊断
  • 照护现场神经诊断
  • 神经退化性疾病诊断套件

第七章 区域和国家分析

  • 全球神经诊断市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球神经诊断市场：国家、绩效与预测（2019-2024、2024-2029、2034）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 神经诊断市场：竞争格局
  • 神经诊断市场：公司简介
    • Nihon Kohden Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Cephalon LLC Overview, Products and Services, Strategy and Financial Analysis
    • Stratus Neuro LLC Overview, Products and Services, Strategy and Financial Analysis
    • Cadwell Industries Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Compumedics Limited Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Ceribell Inc.
  • CND Life Sciences Inc.
  • Lifelines Neuro Inc.
  • ANT Neuro BV
  • Neurovative Diagnostics LLC
  • Firefly Neuroscience Inc
  • IntraNerve Neuroscience Inc
  • NeuroDiagnostics Laboratories LLC
  • Advanced Brain Monitoring Inc
  • Spes Medica Srl
  • BioSignal Group Inc
  • Combinostics Inc.
  • Deymed Diagnostic LLC
  • NeuLine Health Inc.
  • Ridge Diagnostics Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029 年神经诊断市场：提供新机会的国家
  • 2029 年神经诊断市场：细分市场将带来新机会
  • 2029 神经诊断市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r33832u

Neurodiagnostics is a medical field focused on diagnosing and monitoring disorders of the nervous system, which includes the brain, spinal cord, and peripheral nerves. It utilizes advanced technologies and tests to evaluate neurological function, detect abnormalities, and help diagnose conditions such as epilepsy, stroke, multiple sclerosis, neuropathies, and other neurological diseases.

The primary types of neurodiagnostic tools are diagnostic and imaging solutions, as well as in-vitro diagnostics. Diagnostic and imaging solutions include medical technologies and services designed to detect health conditions through various imaging techniques and diagnostic tools. Key technologies in this area include neuroimaging, computed tomography (CT), magnetic resonance imaging (MRI), nuclear medicine imaging (PET, SPECT), near-infrared spectroscopic imaging (NIRS), electroencephalography (EEG), magnetoencephalography (MEG), voxel-based morphometry (VBM), and neuroinformatics. These diagnostic tools are vital for treating conditions such as epilepsy, Alzheimer's disease, Parkinson's disease, stroke, joint health problems, and more, and are used in hospitals, clinics, diagnostic laboratories, imaging centers, and other healthcare settings.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The neurodiagnostic market research report is one of a series of new reports from The Business Research Company that provides neurodiagnostic market statistics, including the neurodiagnostic industry's global market size, regional shares, competitors with a neurodiagnostic market share, detailed neurodiagnostic market segments, market trends and opportunities, and any further data you may need to thrive in the neurodiagnostic industry. This neurodiagnostic market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The neurodiagnostics market size has grown strongly in recent years. It will grow from $9.17 billion in 2024 to $9.79 billion in 2025 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to rise in prevalence of neurological disorders, increase in adoption of advanced imaging technologies, growth in geriatric population, increase in awareness of early disease diagnosis, expanding healthcare infrastructure, and rise in investments in neuroscience research and development.

The neurodiagnostics market size is expected to see strong growth in the next few years. It will grow to $12.68 billion in 2029 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to increasing demand for non-invasive diagnostic techniques, growing prevalence of neurological disorders, rising government investments in healthcare infrastructure, rising awareness and early detection initiatives, and expansion of personalized medicine approaches. Major trends in the forecast period include development of portable EEG devices, integration of AI for improved diagnostic accuracy, enhanced MRI technologies for brain imaging, adoption of wearables for continuous monitoring, advancements in neurogenetic testing, and adoption of real-time data analytics for personalized treatment plans.

The forecast of 6.7% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. neurological care by increasing costs for quantitative Electroencephalography(EEG) headsets and evoked potential testing equipment sourced from Sweden and China, potentially compromising seizure disorder diagnosis and raising neurophysiology lab expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing prevalence of neurological disorders is expected to propel the expansion of the neurodiagnostics market. Neurological disorders, which affect the brain, spinal cord, or nerves, result in various cognitive, motor, and sensory impairments. The increase in these disorders is primarily attributed to factors such as aging populations, environmental influences, lifestyle changes, genetics, and improvements in diagnostic techniques. Neurodiagnostics are crucial for the accurate identification, assessment, and monitoring of these conditions, helping ensure precise diagnoses, informed treatment choices, and effective management of neurological issues. For instance, in April 2023, the National Library of Medicine reported that 6.7 million Americans were living with Alzheimer's disease, a number expected to rise to 13.8 million by 2060. This growing prevalence of neurological conditions is driving the neurodiagnostics market forward.

Companies in the neurodiagnostics market are focusing on technological innovations, including advanced software algorithms, to enhance diagnostic accuracy and improve patient outcomes. These sophisticated algorithms use artificial intelligence (AI) and machine learning techniques to process and analyze data, supporting better decision-making and diagnostics. For example, in October 2023, Ceribell Inc., a US-based medical equipment company, launched the ClarityPro AI algorithm, which represents a significant advancement in diagnosing electrographic status epilepticus (ESE). This advanced software, integrated with the Ceribell EEG system, uses machine learning to analyze EEG waveforms and provide real-time alerts for suspected seizures. ClarityPro is the first acute care device to receive FDA clearance for standalone diagnosis, helping clinicians make quicker, more informed treatment decisions by continuously monitoring brain activity and providing actionable insights.

In July 2022, ArchiMed SAS, a France-based investment firm focused on the healthcare sector, acquired Natus Medical Incorporated for $1.1 billion. This acquisition enhances ArchiMed's position in the neurodiagnostics space by leveraging Natus Medical's expertise in developing medical devices for screening, diagnosing, and treating neurological disorders.

Major players in the neurodiagnostics market are Nihon Kohden Corporation, Cephalon LLC, Stratus Neuro LLC, Cadwell Industries Inc., Compumedics Limited, Ceribell Inc., CND Life Sciences Inc., Lifelines Neuro Inc., ANT Neuro B.V., Neurovative Diagnostics LLC, Firefly Neuroscience Inc, IntraNerve Neuroscience Inc, NeuroDiagnostics Laboratories LLC, Advanced Brain Monitoring Inc, Spes Medica S.r.l., BioSignal Group Inc, Combinostics Inc., Deymed Diagnostic LLC, NeuLine Health Inc., Ridge Diagnostics Inc., Beacon Biosignals Inc., and Intch Inc.

North America was the largest region in the neurodiagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in neurodiagnostics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the neurodiagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The neurodiagnostics market includes revenues earned by entities by providing services such as electroencephalography (EEG), positron emission tomography (PET), cerebrospinal fluid (CSF) analysis, and sleep apnea diagnosis. The market value includes the value of related goods sold by the service provider or included within the service offering. The neurodiagnostic market consists of sales of transcranial magnetic stimulation (TMS) devices, magnetoencephalography (MEG) systems, polysomnography (PSG) devices, and biosensors. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Neurodiagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on neurodiagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for neurodiagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The neurodiagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Diagnostic And Imaging Solutions; In-Vitro Diagnostics
  • 2) By Technology: Neuroimaging Technologies; Computed Tomography (CT); Magnetic Resonance Imaging (MRI); Nuclear Medicine Imaging (PET, SPECT); Near Infrared Spectroscopic Imaging (NIRS); Electro-Encephalography (EEG); Magneto-Encephalography (MEG); Voxel Based Morphometry (VBM); Neuroinformatics
  • 3) By Condition: Epilepsy; Alzheimer's Disease; Parkinson's Disease; Stroke; Joint Health; Other Conditions
  • 4) By End Use : Hospitals And Clinics; Diagnostic Laboratories; Imaging Centers; Other End Uses
  • Subsegments:
  • 1) By Diagnostic And Imaging Solutions: MRI (Magnetic Resonance Imaging) Systems; CT (Computed Tomography) Scanners; EEG (Electroencephalogram) Systems; EMG (Electromyography) Systems; MEG (Magnetoencephalography) Systems; PET (Positron Emission Tomography) Scanners; SPECT (Single Photon Emission Computed Tomography) Scanners; Functional MRI (fMRI) Systems; Intracranial Pressure Monitors
  • 2) By In-Vitro Diagnostics: Blood-Based Diagnostics; Cerebrospinal Fluid (Csf) Analysis; Genetic Testing And Biomarkers; Neurochemical Diagnostics; Point-Of-Care Neurodiagnostics; Diagnostic Kits For Neurodegenerative Disorders
  • Companies Mentioned: Nihon Kohden Corporation; Cephalon LLC; Stratus Neuro LLC; Cadwell Industries Inc.; Compumedics Limited; Ceribell Inc.; CND Life Sciences Inc.; Lifelines Neuro Inc.; ANT Neuro B.V.; Neurovative Diagnostics LLC; Firefly Neuroscience Inc; IntraNerve Neuroscience Inc; NeuroDiagnostics Laboratories LLC; Advanced Brain Monitoring Inc; Spes Medica S.r.l.; BioSignal Group Inc; Combinostics Inc.; Deymed Diagnostic LLC; NeuLine Health Inc.; Ridge Diagnostics Inc.; Beacon Biosignals Inc.; Intch Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Neurodiagnostics Market Characteristics

3. Neurodiagnostics Market Trends And Strategies

4. Neurodiagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Neurodiagnostics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Neurodiagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Neurodiagnostics Market Growth Rate Analysis
  • 5.4. Global Neurodiagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Neurodiagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Neurodiagnostics Total Addressable Market (TAM)

6. Neurodiagnostics Market Segmentation

  • 6.1. Global Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnostic And Imaging Solutions
  • In-Vitro Diagnostics
  • 6.2. Global Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Neuroimaging Technologies
  • Computed Tomography (CT)
  • Magnetic Resonance Imaging (MRI)
  • Nuclear Medicine Imaging (PET, SPECT)
  • Near Infrared Spectroscopic Imaging (NIRS)
  • Electro-Encephalography (EEG)
  • Magneto-Encephalography (MEG)
  • Voxel Based Morphometry (VBM)
  • Neuroinformatics
  • 6.3. Global Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Epilepsy
  • Alzheimer's Disease
  • Parkinson's Disease
  • Stroke
  • Joint Health
  • Other Conditions
  • 6.4. Global Neurodiagnostics Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Diagnostic Laboratories
  • Imaging Centers
  • Other End Uses
  • 6.5. Global Neurodiagnostics Market, Sub-Segmentation Of Diagnostic And Imaging Solutions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • MRI (Magnetic Resonance Imaging) Systems
  • CT (Computed Tomography) Scanners
  • EEG (Electroencephalogram) Systems
  • EMG (Electromyography) Systems
  • MEG (Magnetoencephalography) Systems
  • PET (Positron Emission Tomography) Scanners
  • SPECT (Single Photon Emission Computed Tomography) Scanners
  • Functional MRI (fMRI) Systems
  • Intracranial Pressure Monitors
  • 6.6. Global Neurodiagnostics Market, Sub-Segmentation Of In-Vitro Diagnostics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood-Based Diagnostics
  • Cerebrospinal Fluid (Csf) Analysis
  • Genetic Testing And Biomarkers
  • Neurochemical Diagnostics
  • Point-Of-Care Neurodiagnostics
  • Diagnostic Kits For Neurodegenerative Disorders

7. Neurodiagnostics Market Regional And Country Analysis

  • 7.1. Global Neurodiagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Neurodiagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Neurodiagnostics Market

  • 8.1. Asia-Pacific Neurodiagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Neurodiagnostics Market

  • 9.1. China Neurodiagnostics Market Overview
  • 9.2. China Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Neurodiagnostics Market

  • 10.1. India Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Neurodiagnostics Market

  • 11.1. Japan Neurodiagnostics Market Overview
  • 11.2. Japan Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Neurodiagnostics Market

  • 12.1. Australia Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Neurodiagnostics Market

  • 13.1. Indonesia Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Neurodiagnostics Market

  • 14.1. South Korea Neurodiagnostics Market Overview
  • 14.2. South Korea Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Neurodiagnostics Market

  • 15.1. Western Europe Neurodiagnostics Market Overview
  • 15.2. Western Europe Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Neurodiagnostics Market

  • 16.1. UK Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Neurodiagnostics Market

  • 17.1. Germany Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Neurodiagnostics Market

  • 18.1. France Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Neurodiagnostics Market

  • 19.1. Italy Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Neurodiagnostics Market

  • 20.1. Spain Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Neurodiagnostics Market

  • 21.1. Eastern Europe Neurodiagnostics Market Overview
  • 21.2. Eastern Europe Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Neurodiagnostics Market

  • 22.1. Russia Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Neurodiagnostics Market

  • 23.1. North America Neurodiagnostics Market Overview
  • 23.2. North America Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Neurodiagnostics Market

  • 24.1. USA Neurodiagnostics Market Overview
  • 24.2. USA Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Neurodiagnostics Market

  • 25.1. Canada Neurodiagnostics Market Overview
  • 25.2. Canada Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Neurodiagnostics Market

  • 26.1. South America Neurodiagnostics Market Overview
  • 26.2. South America Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Neurodiagnostics Market

  • 27.1. Brazil Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Neurodiagnostics Market

  • 28.1. Middle East Neurodiagnostics Market Overview
  • 28.2. Middle East Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Neurodiagnostics Market

  • 29.1. Africa Neurodiagnostics Market Overview
  • 29.2. Africa Neurodiagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Neurodiagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Neurodiagnostics Market, Segmentation By Condition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Neurodiagnostics Market Competitive Landscape And Company Profiles

  • 30.1. Neurodiagnostics Market Competitive Landscape
  • 30.2. Neurodiagnostics Market Company Profiles
    • 30.2.1. Nihon Kohden Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Cephalon LLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Stratus Neuro LLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Cadwell Industries Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Compumedics Limited Overview, Products and Services, Strategy and Financial Analysis

31. Neurodiagnostics Market Other Major And Innovative Companies

  • 31.1. Ceribell Inc.
  • 31.2. CND Life Sciences Inc.
  • 31.3. Lifelines Neuro Inc.
  • 31.4. ANT Neuro B.V.
  • 31.5. Neurovative Diagnostics LLC
  • 31.6. Firefly Neuroscience Inc
  • 31.7. IntraNerve Neuroscience Inc
  • 31.8. NeuroDiagnostics Laboratories LLC
  • 31.9. Advanced Brain Monitoring Inc
  • 31.10. Spes Medica S.r.l.
  • 31.11. BioSignal Group Inc
  • 31.12. Combinostics Inc.
  • 31.13. Deymed Diagnostic LLC
  • 31.14. NeuLine Health Inc.
  • 31.15. Ridge Diagnostics Inc.

32. Global Neurodiagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Neurodiagnostics Market

34. Recent Developments In The Neurodiagnostics Market

35. Neurodiagnostics Market High Potential Countries, Segments and Strategies

  • 35.1 Neurodiagnostics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Neurodiagnostics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Neurodiagnostics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer